Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 7Phase 1/2 4Phase NA 2Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 10Prostatic Neoplasms 8Brain Neoplasms 7Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Intraductal, Noninfiltrating 4Uterine Cervical Neoplasms 3Neoplasms 3Lung Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Endometrial Neoplasms 3Oropharyngeal Neoplasms 2Neoplasm Metastasis 2Melanoma 2Glioma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma, Ductal, Breast 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tonsillar Neoplasms 1Symptomatic Osseous Bone Lesions From Any Malignancy 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Skin Diseases 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 16Blood Specimen Collection 8Temozolomide 5Magnetic Resonance Imaging 5Bevacizumab 4Yoga 3Radiotherapy, Intensity-Modulated 3Biopsy 3Transcranial Magnetic Stimulation 2Surveys and Questionnaires 2Restraint, Physical 2Radiosurgery 2Radiation 2Psychosocial Intervention 2Proton Therapy 2Physical Therapy Modalities 2Palliative Care 2Mind-Body Therapies 2Mental Status and Dementia Tests 2Heart Rate 2Gadolinium DTPA 2Exercise 2Elasticity Imaging Techniques 2Drug Therapy 2Diffusion Tensor Imaging 2Congresses as Topic 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Glioma × Radiation × Clear all
NCT06519682 2025-08-29

A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)

The Hospital for Sick Children

Phase NA Recruiting
20 enrolled
CNS

Glioma

NCT00595322 2017-05-23

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
25 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡